Home Economy Eli Lilly signs $2bn deal for AI drug development with Hong Kong biotech
EconomyGlobal Economy

Eli Lilly signs $2bn deal for AI drug development with Hong Kong biotech

Share
Share
Global pharmaceutical corporations are aggressively searching for new medicines in China
Share

Leave a comment

Leave a Reply

Your email address will not be published. Required fields are marked *